COMMUNIQUÉS West-GlobeNewswire
-
Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis
29/05/2026 -
Kane Biotech Announces Grant of Stock Options
29/05/2026 -
Celularity Receives Nasdaq Notice Regarding Form 10-Q
29/05/2026 -
FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
29/05/2026 -
MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval
29/05/2026 -
ASAP Dental Care Expands Evening and Weekend Hours Across Greater Jacksonville to Meet Urgent Dental and Emergency Needs
29/05/2026 -
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
29/05/2026 -
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
29/05/2026 -
ALK to present at the Jefferies Global Healthcare Conference in New York
29/05/2026 -
Ipsen annonce le lancement d'une opération d’actionnariat salarié
29/05/2026 -
Ipsen announces the launch of an Employee Shareholding Plan
29/05/2026 -
MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes
29/05/2026 -
Kun Peng International Ltd. Announces 1-for-10 Reverse Stock Split
29/05/2026 -
Cuprina Holdings Announces Completion of Reverse Stock Split and Requests a Hearing before the Nasdaq Hearings Panel to Maintain Listing
29/05/2026 -
Seer Files ITC Complaint Against Nanomics
29/05/2026 -
PICARD MEDICAL, INC. Issues Letter to Shareholders
29/05/2026 -
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
29/05/2026 -
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
29/05/2026 -
Mud Wtr Reviews: Is This Mushroom Coffee Alternative Worth Drinking?
29/05/2026
Pages